[The role of oral fluoropyrimidines in colorectal cancer treatment--a review].
Oral fluoropyrimidines, such as uracil plus tegafur (UFT), S-1 and capecitabine, have been developed and evaluated in the treatment of colorectal cancer. Their efficacy and safety are not inferior to infusional FU regimens. They provide more convenient therapy and better QOL. Careful observation and management of adverse events to preserve treatment compliance is important.